Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
341.00
+11.19 (3.39%)
At close: Dec 10, 2025, 4:00 PM EST
341.30
+0.30 (0.09%)
After-hours: Dec 10, 2025, 4:08 PM EST
Elevance Health Revenue
Elevance Health had revenue of $50.09B in the quarter ending September 30, 2025, with 12.00% growth. This brings the company's revenue in the last twelve months to $193.26B, up 11.93% year-over-year. In the year 2024, Elevance Health had annual revenue of $175.20B with 2.93% growth.
Revenue (ttm)
$193.26B
Revenue Growth
+11.93%
P/S Ratio
0.38
Revenue / Employee
$1,869,674
Employees
104,200
Market Cap
75.78B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 175.20B | 5.00B | 2.93% |
| Dec 31, 2023 | 170.21B | 14.55B | 9.35% |
| Dec 31, 2022 | 155.66B | 18.72B | 13.67% |
| Dec 31, 2021 | 136.94B | 16.14B | 13.36% |
| Dec 31, 2020 | 120.81B | 17.67B | 17.13% |
| Dec 31, 2019 | 103.14B | 11.80B | 12.92% |
| Dec 31, 2018 | 91.34B | 2.28B | 2.56% |
| Dec 31, 2017 | 89.06B | 4.87B | 5.78% |
| Dec 31, 2016 | 84.19B | 5.79B | 7.38% |
| Dec 31, 2015 | 78.40B | 5.38B | 7.37% |
| Dec 31, 2014 | 73.02B | 2.83B | 4.03% |
| Dec 31, 2013 | 70.19B | 9.68B | 15.99% |
| Dec 31, 2012 | 60.51B | 648.80M | 1.08% |
| Dec 31, 2011 | 59.87B | 2.12B | 3.68% |
| Dec 31, 2010 | 57.74B | -3.00B | -4.94% |
| Dec 31, 2009 | 60.74B | -839.20M | -1.36% |
| Dec 31, 2008 | 61.58B | 1.42B | 2.37% |
| Dec 31, 2007 | 60.16B | 3.98B | 7.08% |
| Dec 31, 2006 | 56.18B | 12.19B | 27.71% |
| Dec 31, 2005 | 43.99B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
ELV News
- 2 days ago - Anthem Blue Cross and Blue Shield Donates Over $60,000 to Support Holiday Food Distributions Across New York - Business Wire
- 2 days ago - Impax U.S. Sustainable Economy Fund Q3 2025 Contributors And Detractors - Seeking Alpha
- 5 days ago - Elevance Health Expands Virtual Assistant to Help Members Navigate Healthcare with Confidence - Business Wire
- 8 days ago - Elevance Health: The Potential Turnaround The Market Isn't Pricing In - Seeking Alpha
- 13 days ago - Artisan Select Equity Fund Q3 2025 Portfolio Review - Seeking Alpha
- 13 days ago - Health Insurers Stocks Reflect Obamacare Subsidy Deal Can Be Reached - Forbes
- 15 days ago - First Eagle Global Equity ETF Q3 2025 Portfolio Update - Seeking Alpha
- 16 days ago - How Elevance Health is Evolving the Healthcare Consumer Experience Through Improved Personalization and Higher Touch Service - Business Wire